Iron Deficiency Anemia (IDA) Clinical Trial
Official title:
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01129843 -
Directly Observed Iron Supplementation to Treat Anemia
|
N/A | |
| Completed |
NCT03754998 -
Community Interventions to Improve Iron and Iodine Status in Mother and Child Dyads in Northern Ghana
|
N/A | |
| Completed |
NCT02410213 -
A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA
|
Phase 2 | |
| Active, not recruiting |
NCT01950247 -
Trial to Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron and to Compare Safety, Effect on Quality of Life, and Resource Utilization of Injectafer vs Intravenous Standard of Care for the Treatment of IDA in an Infusion Center Setting
|
Phase 4 |